virology

TWiV 677: Does antibody really know what time it is?

1 Comment / This Week in Virology / By

Daniel Griffin provides a clinical report on COVID-19, then we discuss rapid deployment of SARS-CoV-2 testing by research laboratories in San Francisco, longitudinal observation of antibodies to SARS-CoV-2 in patients, and listener questions on vaccines, loss of smell, face masks, and more. Click arrow to playDownload TWiV 677 (97 MB .mp3, 162 min)Subscribe (free): iTunes, Google Podcasts, RSS, email Become …

TWiV 677: Does antibody really know what time it is? Read More »

TWiV 675: Forget what you’ve herd about immunity

4 Comments / Commentary, This Week in Virology / By

Daniel Griffin provides a clinical report on COVID-19, then we discuss Bill Foege’s letter to CDC director Robert Redfield, the false promise of herd immunity for COVID-19, secret blueprints for SARS-CoV-2 vaccine trials released, and neuropilin-1 as a possible entry protein for the virus. Click arrow to playDownload TWiV 675 (105 MB .mp3, 174 min)Subscribe (free): iTunes, Google …

TWiV 675: Forget what you’ve herd about immunity Read More »

An explanation for the low quality antibodies produced during serious SARS-CoV-2 infection

Basic virology / By

Although we are less than a year into the SARS-CoV-2 pandemic, it appears that the antibodies induced by infection are often of poor quality, and B cell memory seems limited. An explanation for this outcome might be a consequence of the loss of germinal centers in COVID-19 patients. Examination of lymph nodes and spleen of …

An explanation for the low quality antibodies produced during serious SARS-CoV-2 infection Read More »

We missed SARS-CoV-2, what other coronaviruses are we ignoring?

1 Comment / Basic virology, Information / By

After SARS-Cov came and went in 2003, we learned that bats in China harbor SARS-like coronaviruses with the capacity to infect human cells. This information was largely ignored, otherwise we would have stopped this pandemic in its tracks. A coronavirus that went from bats to pigs might represent yet another threat to human health. Swine …

We missed SARS-CoV-2, what other coronaviruses are we ignoring? Read More »

TWiV 672: Black in Microbiology with Ari Kozik and Kishana Taylor

This Week in Virology / By

Ari and Kishana, two of the founders of Black in Microbiology, join TWiV to discuss the goals of the organization, then we review pauses of J&J and Lilly COVID-19 vaccine trials, preclinical studies of Regeneron’s SARS-CoV-2 monoclonal antibody cocktail, reinfection of a patient in Nevada, and listener questions. Click arrow to playDownload TWiV 672 (76 MB …

TWiV 672: Black in Microbiology with Ari Kozik and Kishana Taylor Read More »

Scroll to Top